oxiracetam

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We investigated the effect of the nootropic substance oxiracetam on the impairment of memory induced in mice by the non… (More)
Is this relevant?
1995
1995
The effects of oxiracetam on hippocampally-mediated learning performance and hippocampal protein kinase C (PKC) were examined in… (More)
Is this relevant?
1995
1995
The effects of a nootropic drug, oxiracetam (50-100-200 mg/kg ip), and a potent antioxidant agent, ascorbic acid (62.5-125-250 mg… (More)
Is this relevant?
1992
1992
Twenty-four carefully assessed patients with probable Alzheimer's disease were enrolled in a double-blind, placebo-controlled… (More)
Is this relevant?
1992
1992
A multicentre, double-blind, between-patient study was carried out to evaluate the efficacy and tolerability of oxiracetam (800… (More)
Is this relevant?
1990
1990
Nootropics are drugs employed to improve cognitive functions, particularly learning and memory ability, and to prevent their… (More)
Is this relevant?
1990
1990
The efficacy and tolerability of the monoamine oxidase B inhibitor selegiline and of the nootropic agent oxiracetam were compared… (More)
Is this relevant?
1989
1989
Oxiracetam administered systemically to rats as a 14C radiolabelled drug (200 mg/kg p.o. or 100 mg/kg intra-artery) enters the… (More)
Is this relevant?
1989
1989
1. Initial clinical trials in approximately 200 patients with dementias of diverse etiology suggested that oxiracetam, a… (More)
Is this relevant?
1987
1987
The effect of cognition-enhancing agents oxiracetam and aniracetam on scopolamine-induced amnesia and brain acetylcholine… (More)
Is this relevant?